CalciMedica, Inc. (CALC) vs Xenetic Biosciences, Inc. (XBIO)
A side-by-side comparison of CalciMedica, Inc. and Xenetic Biosciences, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
CALC
CalciMedica, Inc.
$1.49HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
XBIO
Xenetic Biosciences, Inc.
$2.12HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Total return — CALC vs XBIO
growth of $100 · dividends reinvested · last 3yCALC -94.7% (-62.5%/yr)XBIO -36.8% (-14.2%/yr)XBIO compounded faster over this window
Log scale — wide-divergence pair
CALC XBIO
CALC vs XBIO: by the numbers
- •XBIO is the larger company ($5M vs $5M market cap).
- •Both run net losses; CALC's is the smaller (0.00% vs -75.90% net margin).
Metrics side by side
Valuation
| Metric | CALC | XBIO |
|---|---|---|
| P/S ratio | N/A | 1.49 |
| P/B ratio | 0.85 | 0.80 |
Profitability
| Metric | CALC | XBIO |
|---|---|---|
| Gross margin | 0.00% | 100.00% |
| Operating margin | 0.00% | -95.23% |
| Net margin | 0.00% | -75.90% |
| ROE | -385.27% | -40.76% |
| ROIC | -122.56% | -43.50% |
Growth (annualized)
| Metric | CALC | XBIO |
|---|---|---|
| Revenue CAGR (5Y) | N/A | 34.31% |
| Total return CAGR (5Y) | N/A | -34.54% |
Go deeper
Dig into the metrics
CalciMedica ROEXenetic Biosciences ROECalciMedica operating marginXenetic Biosciences operating marginCalciMedica revenue growthXenetic Biosciences revenue growthCalciMedica free cash flowXenetic Biosciences free cash flow
CalciMedica & Xenetic Biosciences appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.